These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36216527)

  • 21. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manually guided botulinum toxin type A submandibular injections for the treatment of sialorrhea in tube-fed patients with advanced amyotrophic lateral sclerosis.
    Rodriguez-Murphy E; Marti-Bonmati E; Camps-Seguí E; Bagán JV
    Am J Health Syst Pharm; 2011 Sep; 68(18):1680-1. PubMed ID: 21880878
    [No Abstract]   [Full Text] [Related]  

  • 24. Teaching Video NeuroImages: Jaw Clonus in Amyotrophic Lateral Sclerosis.
    Goel A; Shree R; Kathuria H; Mehta S; Lal V; Mahesh KV
    Neurology; 2021 May; 96(20):e2563. PubMed ID: 33109624
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis.
    Restivo DA; Lanza S; Marchese-Ragona R; Palmeri A
    Gastroenterology; 2002 Nov; 123(5):1749-50. PubMed ID: 12404262
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment.
    Stokholm MG; Bisgård C; Vilholm OJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):516-20. PubMed ID: 23984863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral Sclerosis.
    Mongin M; Debs R; Le Forestier N; Lenglet T; Salachas F; Pradat PF; Amador MD; Bruneteau G; Degos B
    Rev Neurol (Paris); 2020 Dec; 176(10):870-873. PubMed ID: 32653215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Sialorrhea in Amyotrophic Lateral Sclerosis #299.
    Scott K; Shannon R; Roche-Green A
    J Palliat Med; 2016 Jan; 19(1):110-1. PubMed ID: 26651368
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis.
    Manrique D
    Braz J Otorhinolaryngol; 2005; 71(5):566-9. PubMed ID: 16612515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
    Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
    Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis.
    Stone CA; O'Leary N
    J Pain Symptom Manage; 2009 Feb; 37(2):246-58. PubMed ID: 18676117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a treatment effective and safe for sialorrhea in people with amyotrophic lateral sclerosis (ALS)? Summary of a Cochrane Systematic Review.
    Cantisani TA
    Neurol Sci; 2023 Sep; 44(9):3083-3085. PubMed ID: 37326935
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of sialorrhea with botulinum toxin: an overview].
    Hagenah J; Kahl KG; Steinlechner S; Lencer R; Klein C
    Nervenarzt; 2005 Apr; 76(4):418-25. PubMed ID: 15448912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
    Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
    Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study.
    Paracka L; Kollewe K; Klietz M; Petri S; Dressler D
    J Neural Transm (Vienna); 2019 Oct; 126(10):1341-1345. PubMed ID: 31317261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
    Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
    Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin for the treatment of sialorrhea: a meta-analysis.
    Vashishta R; Nguyen SA; White DR; Gillespie MB
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parotid gland injections of botulinum toxin a are effective in treating sialorrhea in amyotrophic lateral sclerosis.
    Scott KR; Kothari MJ; Venkatesh YS; Murphy T; Simmons Z
    J Clin Neuromuscul Dis; 2005 Dec; 7(2):62-5. PubMed ID: 19078785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.